PTPN1 and central nervous system cancer: Our findings suggest that in the presence of a low-concentration of pristimerin, cell viability and expression of PTPN1 were significantly down-regulated, while pristimerin levels were elevated; and higher concentration of pristimerin could induce apoptosis in glioma cells.